FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study.

FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study.
复制标题

FcgammaRIIIA-158V 和类风湿性关节炎:一项确认研究。

DOI:
--
复制
发表时间:
2003
期刊:
影响因子:
5.5
通讯作者:
J. Isaacs
J. Isaacs
中科院分区:
医学1区
文献类型:
--
作者:
A. Morgan;V. H. Keyte;S. Babbage;J. Robinson;F. Ponchel;J. Barrett;B. Bhakta;S. Bingham;M. Buch;P. Conaghan;A. Gough;M. Green;C. Lawson;C. Pease;A. Markham;W. Ollier;P. Emery;Jane Worthington;J. Isaacs

文献摘要

被引文献

相似文献

目标 开发一种用于Fc γ RIIIA-158 V/F多态性基因分型的稳健检测方法,并确认Fc γ RIIIA-158 V等位基因与类风湿性关节炎(RA)之间的推定关联。 方法 该等位基因关联研究检查了Fc γ RIIIA-158 V/F多态性与RA的关联。一种新的单链构象多态性分析被用来基因型828 RA患者和581对照从英国。 结果 Fc γ RIIIA-158 V等位基因与RA(P=0.02)和结节(P=0.04)相关。该高亲和力等位基因纯合子个体患RA(OR 1.53,95% CI 1.08-2.18)和结节发生(OR 2.20,95% CI 1.20-4.01)的风险显著增加。没有证据表明与共享表位相互作用。 结论 我们已经开发了一种新的检测方法对Fc γ RIIIA-158 F/V多态性进行基因分型,并证实Fc γ RIIIA-158 V等位基因的纯合性与UK高加索人RA相关,特别是在那些患有结节的个体中,这表明Fc γ RIIIA可能在确定疾病严重程度或结节本身的发展中发挥作用。
OBJECTIVES To develop a robust assay for genotyping the FcgammaRIIIA-158V/F polymorphism and to confirm the putative association between the FcgammaRIIIA-158V allele and rheumatoid arthritis (RA). METHODS This allelic association study examined the FcgammaRIIIA-158V/F polymorphism for association with RA. A novel single-stranded conformational polymorphism assay was used to genotype 828 RA patients and 581 controls from the UK. RESULTS The FcgammaRIIIA-158V allele was associated with both RA (P=0.02) and nodules (P=0.04). Individuals homozygous for this higher affinity allele had a significantly increased risk of RA (OR 1.53, 95% CI 1.08-2.18) and the development of nodules (OR 2.20, 95% CI 1.20-4.01). There was no evidence of an interaction with the shared epitope. CONCLUSIONS We have developed a novel assay to genotype the FcgammaRIIIA-158F/V polymorphism and confirmed that homozygosity for the FcgammaRIIIA-158V allele is associated with UK Caucasian RA, particularly in those individuals with nodules, suggesting FcgammaRIIIA may play a role in determining disease severity or in the development of nodules per se.